Showing results (11-20 of 128) with videos related to
Sort By:
Pageof 13
The Journal of Pain|March 27, 2010
Characterization of Fasudil in preclinical models of painJanel M Boyce-Rustay, Gricelda H Simler, Steve McGaraughty, et al.Alcoholism, Clinical and Experimental Research|November 23, 2006
Ethanol-related behaviors in serotonin transporter knockout miceJanel M Boyce-Rustay, Lisa M Wiedholz, Rachel A Millstein, et al.Neuropharmacology|August 26, 2009
Comparison of mechanical allodynia and the affective component of inflammatory pain in ratsJanel M Boyce-Rustay, Chengmin Zhong, Rebecca Kohnken, et al.Neuropharmacology|July 16, 2008
Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stressJanel M Boyce-Rustay, Benjamin Palachick, Kathryn Hefner, et al.Biochemical Pharmacology|December 14, 2011
A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in ratsVictoria E Scott, Timothy A Vortherms, Wende Niforatos, et al.Psychopharmacology|March 5, 2013
Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonistThomas J Hudzik, Ana Basso, Janel M Boyce-Rustay, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 16, 2006
Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanismLynette C Daws, Sylvia Montañez, Jaclyn L Munn, et al.Pharmacology Research & Perspectives|August 2, 2019
Therapeutic potential of adenosine kinase inhibition-RevisitedMichael F JarvisExpert Opinion on Therapeutic Targets|July 30, 2003
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic painMichael F JarvisCurrent Protocols in Pharmacology|February 11, 2014
Characterization of P1 (adenosine) purinoceptorsMichael F JarvisPageof 13